The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 study of EPI-7386 in combination with enzalutamide (enz) compared with enz alone in subjects with metastatic castration-resistant prostate cancer (mCRPC).
 
Andrew Leonard Laccetti
Consulting or Advisory Role - Bayer; Bayer; Guidepoint Global; Third Bridge
 
Gurkamal S. Chatta
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb
 
Nicholas Iannotti
No Relationships to Disclose
 
Christos Kyriakopoulos
Stock and Other Ownership Interests - Biogen; Epic Systems (I)
Consulting or Advisory Role - AVEO; EMD Serono; Exelixis; Janssen Oncology; Janssen Oncology; Sanofi
Research Funding - AstraZeneca; ESSA; Gilead Sciences; Pionyr; Sanofi
 
Karen Villaluna
Employment - ESSA
Stock and Other Ownership Interests - ESSA
 
Ronan Le Moigne
Employment - ESSA
Stock and Other Ownership Interests - ESSA
 
Alessandra Cesano
Employment - ESSA
Stock and Other Ownership Interests - ESSA